Showing 181 - 200 results of 454 for search '"cervical cancer"', query time: 0.06s Refine Results
  1. 181
  2. 182

    Durvalumab and tremelimumab in combination with metronomic oral vinorelbine for recurrent advanced cervical cancer: an open-label phase I/II study by Pernelle Lavaud, Esma Saada-Bouzid, Renaud Sabatier, Olivia Le Saux, Thibault de la Motte Rouge, Anthony Gonçalves, Elodie Coquan, Jean-Sébastien Frenel, Marta Jiménez, Alice Hervieu, Laurent Mathiot, François Legrand, Claire Cropet, Edith Borcoman, Emmanuelle Charafe

    Published 2025-01-01
    “…We present the results of the recurrent advanced cervical cancer cohort.Methods Patients received tremelimumab (intravenously, 75 mg, every four weeks (Q4W); four cycles max) plus durvalumab (intravenously, 1,500 mg, Q4W; 26 cycles max) and metronomic oral vinorelbine (40 mg, every three weeks (3QW)) until disease progression. …”
    Get full text
    Article
  3. 183
  4. 184

    Knowledge, Attitude, and Practice (KAP) toward Cervical Cancer Screening among Adama Science and Technology University Female Students, Ethiopia by Almaz Tadesse, Mesfin Tafa Segni, Hailu Fekadu Demissie

    Published 2022-01-01
    “…Background. Cervical cancer is a complication of Human Papillomavirus (HPV) infection is the second most common cancer in women worldwide. …”
    Get full text
    Article
  5. 185

    Morphine in Combination with Ketamine Improves Cervical Cancer Pain and Suppresses Immune Function via the JAK3/STAT5 Pathway by Yurong Jiang, Tong Li, Yi Qian, Xiaoming Zuo, Jinmei Liu

    Published 2022-01-01
    “…This study aimed to explore the role of morphine and ketamine on cancer pain and T cells of patients with cervical cancer (CC). Methods. T cells were isolated from peripheral blood mononuclear cells (PBMC) of CC patients by positive selection using anti-CD3 beads. …”
    Get full text
    Article
  6. 186
  7. 187

    Multiomics profiling reveals the benefits of gamma-delta (γδ) T lymphocytes for improving the tumor microenvironment, immunotherapy efficacy and prognosis in cervical cancer by Xiaofeng Wang, Chen Li, Jie Chen, Zhiqiang Wu, Zhen Zhang, Junyi Li, Lu Yu, Yong Guan, Yuhan Zhang, Yuanjie Cao, Yancheng Liu, Hui Bai, Shaochuan Liu, Miaomiao Gao, Chenglu Lu, Zhen Tao, Zhiyong Yuan

    Published 2024-01-01
    “…Definitely, γδ T cells play a beneficial role in the prognosis of patients with cervical cancer. First, γδ T cells exert direct cytotoxic effects in the tumor microenvironment of cervical cancer through the dynamic evolution of cellular states at both poles. …”
    Get full text
    Article
  8. 188
  9. 189
  10. 190
  11. 191
  12. 192
  13. 193

    FTO Facilitates Cervical Cancer Malignancy Through Inducing m6A‐Demethylation of PIK3R3 mRNA by Bingxin Chen, Liming Wang, Xiaomin Li, Ci Ren, Chun Gao, Wencheng Ding, Hui Wang

    Published 2024-12-01
    “…ABSTRACT Background The incidence rate and mortality of cervical cancer rank the fourth in the global female cancer. …”
    Get full text
    Article
  14. 194
  15. 195
  16. 196
  17. 197
  18. 198

    Factors associated with cervical cancer screening among women of reproductive age in Moshi municipality, Kilimanjaro, Tanzania: a cross-sectional study by Sia E Msuya, Jeremiah John Hhera, Regina Dahaye, Witness Erasto Zakayo, Yohana Z Kazula, Seif Abdul, Redempta Mamseri

    Published 2025-01-01
    “…Objective Screening for cervical cancer has been a globally advocated preventive strategy to reduce cervical cancer morbidity and mortality. …”
    Get full text
    Article
  19. 199

    Clinical Study of Sentinel Lymph Node Detection to Evaluate Pelvic Lymph Node Metastasis to Determine the Prognosis of Patients with Early Cervical Cancer by Peipei Li, Shuai Feng, Guodong Zhou, Lu Zhang, Xiugui Sheng, Dapeng Li

    Published 2022-01-01
    “…However, the SLN metastasis detection via SLN biopsy in early-stage cervical cancer remains controversial. The current study is aimed at investigating the feasibility and accuracy of combined tracer method for localization of SLN in initial stages of cervical cancer and to evaluate the clinical value of SLN biopsy in replacing pelvic lymph node resection. …”
    Get full text
    Article
  20. 200

    Activation of FGD5-AS1 Promotes Progression of Cervical Cancer through Regulating BST2 to Inhibit Macrophage M1 Polarization by Guokun Liu, Xuan Du, Li Xiao, Qing Zeng, QianLing Liu

    Published 2021-01-01
    “…FGD5-AS1 and BST2 expression was significantly upregulated in cervical cancer cells. Then, the decrease of FGD5-AS1 greatly repressed cervical cancer cell growth in vitro. …”
    Get full text
    Article